Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

EpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023

Published: Nov-2014 | Format: PDF | GlobalData | Number of pages: 49 | Code: MRS - 2058

 

Type 1 diabetes is a type of diabetes that accounts for 10% of all diabetes cases. The condition occurs as a result of the autoimmune destruction of pancreatic beta cells, which are responsible for producing insulin a hormone that regulates blood sugar. Type 1 diabetes, formerly referred to as insulin-dependent diabetes, mostly develops in children and young adults. Hence, it has also been called juvenile diabetes, although this term is no longer frequently used.

 

GlobalData epidemiologists forecast an increase in the diagnosed prevalent cases of type 1 diabetes in the 8MM. The diagnosed prevalent cases of type 1 diabetes in the 8MM will grow by 40.40% over the next decade, from 6.02 million prevalent cases in 2013 to 8.45 million prevalent cases in 2023.

 

To forecast the diagnosed prevalent cases of type 1 diabetes in the 8MM, GlobalData epidemiologists selected nationally representative population-based studies that provided diagnosed prevalence data in the 8MM. Furthermore, GlobalData epidemiologists segmented the prevalent cases of type 1 diabetes by BMI in each market. These BMI segmentations could provide valuable insight into potential patient populations that are eligible for targeted screening programs.

 

Scope

 

  • The Type 1 Diabetes EpiCast Report provides an overview of the risk factors, comorbidities, and the global and historical trends for type 1 diabetes in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and Canada). In addition, the report includes a 10-year epidemiological forecast for the diagnosed prevalent cases of type 1 diabetes segmented by age (ages 0-14 years,15-29 years, 30-44 years, 45-59 years, 60-74 years, and =75 years) and sex. Furthermore, the report provides the distribution of diagnosed prevalent cases of type 1 diabetes segmented by body mass index (BMI) (kg/m2) (BMI The Type 1 Diabetes epidemiology report is written and developed by Mastersand PhD-level epidemiologists.
  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.

 

Reasons to buy

 

  • Develop business strategies by understanding the trends shaping and driving the global type 1 diabetes market.
  • Quantify patient populations in the global type 1 diabetes market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups, sex that present the best opportunities for type 1 diabetes therapeutics in each of the markets covered.

Table of Contents

 

1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6

 

2 Introduction 7
2.1 Catalyst 7
2.2 Related Reports 7
2.3 Upcoming Related Reports 8

 

3 Epidemiology 9
3.1 Disease Background 9
3.2 Risk Factors and Comorbidities 10
3.3 Global Trends 11
3.3.1 US 12
3.3.2 5EU 12
3.3.3 Japan 13
3.3.4 Canada 14
3.4 Forecast Methodology 14
3.4.1 Sources Used 16
3.4.2 Sources Not Used 19
3.4.3 8MM, Forecast Assumptions and Methods - Diagnosed Prevalent Cases of Type 2 Diabetes in Persons Ages ?20 Years 20
3.4.4 8MM, Forecast Assumptions and Methods - Diagnosed Prevalent Cases of Type 1 Diabetes 23
3.5 Epidemiological Forecast for Type 1 Diabetes (2013-2023) 29
3.5.1 Diagnosed Prevalent Cases of Type 1 Diabetes 29
3.5.2 Age-Specific Diagnosed Prevalent Cases of Type 1 Diabetes 31
3.5.3 Sex-Specific Diagnosed Prevalent Cases of Type 1 Diabetes 32
3.5.4 Age-Standardized Diagnosed Prevalence of Type 1 Diabetes 34
3.5.5 Diagnosed Prevalent Cases of Type 1 Diabetes Segmented by Body Mass Index (BMI) 36
3.6 Discussion 37
3.6.1 Epidemiological Forecast Insight 37
3.6.2 Limitations of the Analysis 38
3.6.3 Strengths of the Analysis 39

 

4 Appendix 40
4.1 Bibliography 40
4.2 About the Authors 44
4.2.1 Epidemiologists 44
4.2.2 Reviewers 44
4.2.3 Director of Epidemiology 46
4.2.4 Global Head of Healthcare 47
4.3 About GlobalData 47
4.4 About EpiCast 48
4.5 Disclaimer 48

 

List of Tables

 

Table 1: Risk Factors and Comorbidities for Type 1 Diabetes 11
Table 2: 8MM, Sources of Epidemiological Data Used to Forecast the Diagnosed Prevalent Cases of Type 1 Diabetes 15
Table 3: 8MM, Sources of Epidemiological Data Used for the Prevalent Cases of Type 1 Diabetes Segmented by BMI 15
Table 4: 8MM, Sources Not Used in the Epidemiological Analysis of Type 1 Diabetes 20
Table 5: 8MM, Diagnosed Prevalent Cases of Type 1 Diabetes, All Ages, Both Sexes, N, 2013-2023 30
Table 6: 8MM, Diagnosed Prevalent Cases of Type 1 Diabetes, by Age, Both Sexes, N (Row %), 2013 31
Table 7: 8MM, Diagnosed Prevalent Cases of Type 1 Diabetes, by Sex, All Ages, N (Row %), 2013 33

 

List of Figures

 

Figure 1: 8MM, Diagnosed Prevalent Cases of Type 1 Diabetes, All Ages, Both Sexes, N, 2013-2023 30
Figure 2: 8MM, Diagnosed Prevalent Cases of Type 1 Diabetes, by Age, Both Sexes, N, 2013-2023 32
Figure 3: 8MM, Diagnosed Prevalent Cases of Type 1 Diabetes, by Sex, All Ages, N, 2013 34
Figure 4: 8MM, Age-Standardized Diagnosed Prevalence (%) of Type 1 Diabetes, All Ages, by Sex, 2013 35
Figure 5: 8MM, Diagnosed Prevalent Cases of Type 1 Diabetes, All Ages, by BMI (kg/m2), 2013 36


 

 

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)3995 View Pricing